Corvus Pharmaceuticals (C17) Q2 2024 Earnings Report
DE:C17 Q2 2024 EPS Results
- Actual EPS
- -EUR 0.06
- Consensus EPS
- -EUR 0.10
- Beat/Miss
- Beat by +EUR 0.04
- One Year Ago EPS
- -EUR 0.13
DE:C17 Q2 2024 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/06/2024
- Time
- After Close
- Conference Call
- Tuesday, August 6, 2024
DE:C17 Upcoming Earnings
Corvus Pharmaceuticals's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
DE:C17 Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:C17 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | -0.17- | -0.11 | ― | ― |
| Aug 06, 2026 | 2026 (Q2) | -0.14-0.17 | -0.09 | -90.00% (-0.08) | |
| May 07, 2026 | 2026 (Q1) | -0.13-0.13 | -0.12 | -15.38% (-0.02) | |
| Mar 12, 2026 | 2025 (Q4) | -0.12-0.13 | -0.16 | 16.67% (+0.03) | |
| Nov 04, 2025 | 2025 (Q3) | -0.11-0.11 | -0.54 | 80.00% (+0.43) | |
| Aug 07, 2025 | 2025 (Q2) | -0.12-0.09 | -0.06 | -42.86% (-0.03) | |
| May 08, 2025 | 2025 (Q1) | -0.11-0.12 | -0.11 | -8.33% (-0.01) | |
| Mar 25, 2025 | 2024 (Q4) | -0.10-0.16 | -0.13 | -28.57% (-0.04) | |
| Nov 12, 2024 | 2024 (Q3) | -0.10-0.54 | -0.11 | -400.00% (-0.43) | |
| Aug 06, 2024 | 2024 (Q2) | -0.10-0.06 | -0.13 | 50.00% (+0.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed